Weight-Loss Injections May Dramatically Reduce Dementia Risk Wednesday, June 25, 2025 dementia semaglutide ozempic wegovy type2diabetes alzheimers glp1r weightloss cardiovascular prevention A groundbreaking study suggests that semaglutide, the active ingredient in diabetes drug Ozempic and weight-loss injection Wegovy, could significantly decrease the risk of dementia in individuals with type 2 diabetes. … Read More